Sanjay Raval & Biren Patel, Directors

Dharmesh Patel, General Manager

India’s ophthalmic and surgical sectors are accelerating at an unprecedented pace with three converging trends shaping its future: a rising diabetes burden, technology democratization, and domestic manufacturing advancements. An increasing ageing population, rising chronic conditions and greater access to healthcare are expanding demand for advanced diagnostic and surgical solutions. Beyond the metros, super-specialty hospitals and day-care surgical centers, and specialty clinics are increasingly penetrating tier-II cities, rapidly decentralizing eyecare. Simultaneously, India's manufacturing process is maturing, with policy design promoting local production. The transition from standalone instruments to integrated diagnostic ecosystems where imaging, analytics, and workflow connectivity converge is shaping the sector’s future.

At the forefront of this intersection is Lab Medica, a visionary organization bridging global technology and local accessibility. The firm does not just distribute equipment; it engineers access to international-grade ophthalmic technology with Indian affordability and service responsiveness. Under Eyevis, its in-house brand, the company addresses affordability challenges by leveraging a hybrid model that combines selective imports with local manufacturing and assembly. Lab Medica anchors its impact in long-term partnerships, strengthening every installation with responsive service infrastructure, remote diagnostics, preventive care, and structured clinical training to ensure sustained performance, confidence, and measurable clinical value.

Driving Ophthalmic Advancement with Purpose

Founded in 2002, Lab Medica was created with a singular focus: to introduce the latest global ophthalmic technologies to the Indian eye care community while boosting access and affordability.

The company represents internationally reputed ophthalmic manufacturers with decades of legacy. It brings globally trusted innovation and engineering depth to India.

Lab Medica’s mission centers on sourcing and supplying equipment that meets the highest standards of safety, reliability, and clinical relevance for ophthalmic applications.

With a strong foundation of more than 8,000 customers, the organization has consistently prioritized long-term relationships over transactional growth.

Lab Medica has built a reputation for personalized after-sales service, setting high benchmarks in technical responsiveness and clinical support.

A continuous commitment to improvement ensures advanced technology remains accessible, economically viable, and aligned with the evolving needs of Indian ophthalmology

Developing a Robust Ophthalmic Tech Ecosystem

Lab Medica has built a comprehensive ophthalmic technology portfolio spanning diagnostics, surgical support, and clinical workflow solutions. The company’s product range is designed to address the full spectrum of ophthalmic practice, covering anterior and posterior segment diagnostics, intraocular pressure assessment, surgical visualization, and functional testing.

Within anterior segment diagnostics, the portfolio includes corneal topography, dry eye diagnosis systems, specular microscopy, digital refraction and keratometry platforms, and ophthalmic ultrasound imaging. For glaucoma screening and intraocular pressure assessment, Lab Medica offers non-contact and rebound tonometry systems.

Retinal and posterior segment imaging forms another key segment, with fundus imaging systems and OCT platforms equipped with AI-based reporting and advanced ocular diagnostic capabilities. Surgical visualization is supported through ophthalmic surgical microscopes integrated with 4K documentation suites and wide-angle fundus viewing systems.

In addition, the company provides portable ERG systems, visual field perimetry, and neonatal ROP fundus cameras, ensuring coverage across specialized diagnostic requirements.

“Our portfolio has been developed with clinical continuity in mind. We are not focused on isolated devices, but on building a connected ecosystem that supports diagnosis, documentation, and surgical precision. Every system under the Eyevis platform reflects our emphasis on optical accuracy, ergonomic design, and operational dependability in real-world clinical settings”, shares Sanjay Raval, Director.

This breadth allows institutions to standardize procurement across multiple subspecialties while maintaining technology consistency within their clinical ecosystem. Rather than functioning as isolated devices, these systems are positioned to complement one another, supporting diagnostic accuracy, documentation, and surgical decision-making in a coordinated manner.

Disciplined Manufacturing, Quality Governance

Lab Medica operates under internationally recognized med­ical device quality systems that emphasize traceability, pro­cess control, and performance validation. Critical optical and electronic components are sourced from established global partners and integrated through structured domestic manufacturing workflows.

Each product undergoes calibration, safety evaluation, and performance verification prior to deployment. “Quality is not treated as a compliance requirement within our organization; it is an operational discipline. From sourcing precision components to final assembly and calibration, we follow defined validation processes to ensure consistency. Our objective is to deliver equipment that clinicians can trust for long-term accuracy, not just initial performance”, adds Biren Patel, Director.

Beyond manufactur­ing, lifecycle reliabili­ty is reinforced through structured installation protocols, preventive main­tenance programs, and tech­nical documentation stan­dards. Its service engineers and application teams are trained to sustain system performance and en­sure operational continuity.

This integration of global component sourcing, controlled domestic manufacturing, and structured post-installation support enables the com­pany to deliver systems aligned with international expecta­tions while remaining suited to Indian operating conditions.

Digital Integrations and AI

Ophthalmology is increasingly moving toward digital integration and data-supported clinical workflows, and form a key part of Lab Medica’s product evolution. The company’s systems increasingly incorporate automated measurement algorithms that reduce operator variability and enhance repeatability. Digital imaging capabilities enable longitudinal patient documentation and improved workflow efficiency.

AI-assisted screening pathways, particularly in retinal and anterior segment diagnostics, are being embedded to strengthen early detection and structured reporting. Yet, the company maintains a clear philosophy regarding technology adoption. The emphasis remains on embedding intelligence within routine workflows rather than layering complexity.

“Our goal is not merely to add technology layers but to ensure that advanced capabilities remain clinically intuitive and financially accessible. We believe AI in ophthalmology should augment clinicians, not complicate practice. Our roadmap focuses on embedding practical intelligence within routine diagnostic workflows rather than creating unnecessary complexity”, further adds Biren Patel, Director.

These developments are designed to improve workflow efficiency without disrupting established clinical processes. By aligning technology upgrades with existing practice patterns, the company ensures smoother adoption and faster clinical integration.

Future Roadmap

Lab Medica began with a focused vision to bring advanced ophthalmic technology within reach of Indian clinicians. Over time, it has evolved from a distribution-oriented organization into a vertically integrated ophthalmic solutions provider, supported by global partnerships and domestic manufacturing capability.

In this journey, the firm has achieved numerous milestones including: establishing collaborations with international ophthalmic technology manufacturers and launching the Eyevis brand to support indigenous device development. It has also expanded its installed base across hospitals and teaching institutions; and built a structured service and application support network. The company has also strengthened its presence within government and institutional healthcare segments.

Looking ahead, the company’s roadmap includes expansion of indigenous manufacturing under the Eyevis platform, introduction of next-generation digital and AI-enabled diagnostics. It aspires to strengthen export presence in emerging healthcare markets, develop integrated ophthalmic diagnostic ecosystems, and continue investment in service infrastructure and clinical training programs.

“Our long-term vision is to position Lab Medica as a leading Indian ophthalmic technology supplier with global relevance. We are committed to expanding indigenous manufacturing, strengthening digital capability, and investing in service infrastructure. Sustainable growth for us is built on credibility, clinical reliability, and long-term partnerships with institutions we serve”, concludes Sanjay Raval.

Through structured engineering discipline, digital integration, and lifecycle support, Lab Medica continues to advance its role as a dependable ophthalmic technology partner.